Keisuke Goda is currently a professor in the Department of Chemistry at the University of Tokyo, an adjunct professor in the Department of Bioengineering at University of California, Los Angeles (UCLA), and an adjunct professor in the Institute of Technological Sciences at Wuhan University. His research group aims to develop serendipity-enabling technologies based on laser-based molecular imaging and spectroscopy together with microfluidics and computational analytics, use them to push the frontiers of human knowledge and understanding, and produce global leaders who will shape the future of biology and medicine. He obtained a B.A. degree summa cum laude from the University of California, Berkeley in 2001 and a Ph.D. degree from the Massachusetts Institute of Technology (MIT) in 2007, both in physics. At MIT, he worked on the development of quantum-enhancement techniques in the Laser Interferometer Gravitational-Wave Observatory (LIGO) group that received the 2017 Nobel Prize in physics for the detection of gravitational waves. He then joined the Department of Electrical Engineering at UCLA as a postdoctoral researcher where he worked on laser-based ultrafast optical imaging and spectroscopy and microfluidic biotechnology. In 2012, he joined the Department of Chemistry at the University of Tokyo as a professor. In 2019, he joined both the Department of Bioengineering at UCLA and the Institute of Technological Sciences at Wuhan University as an adjunct professor. From 2014 to 2019, as a program manager of the "Planned Serendipity" program within ImPACT funded by the Cabinet Office, Government of Japan, he formed and led an international, cross-institutional, interdisciplinary team of >50 researchers at >20 institutions in >10 disciplines to develop the world’s first intelligent image-activated cell sorting (iIACS) technology. In 2018, he and his colleagues launched CYBO, Inc., a startup to commercialize the technology to help researchers and medical doctors.